Skip to main content

S.F. biotech races potential COVID-19 drug toward clinical trial

The antibody latches on to a spot found on both the COVID and SARS coronaviruses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.